277 related articles for article (PubMed ID: 26012253)
21. Tacrolimus strongly inhibits multiple human UDP-glucuronosyltransferase (UGT) isoforms.
Liu XY; Fang ZZ; Dong PP; Shi XH; Teng YJ; Sun XY
Pharmazie; 2012 Sep; 67(9):804-8. PubMed ID: 23016456
[TBL] [Abstract][Full Text] [Related]
22. In vitro inhibition of UGT1A3, UGT1A4 by ursolic acid and oleanolic acid and drug-drug interaction risk prediction.
Xie H; Wu J; Liu D; Liu M; Zhang H; Huang S; Xiong Y; Xia C
Xenobiotica; 2017 Sep; 47(9):785-792. PubMed ID: 27600106
[TBL] [Abstract][Full Text] [Related]
23. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.
Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M
Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory Effect of Hesperetin and Naringenin on Human UDP-Glucuronosyltransferase Enzymes: Implications for Herb-Drug Interactions.
Liu D; Wu J; Xie H; Liu M; Takau I; Zhang H; Xiong Y; Xia C
Biol Pharm Bull; 2016; 39(12):2052-2059. PubMed ID: 27904048
[TBL] [Abstract][Full Text] [Related]
25. Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation.
Lu H; Fang ZZ; Cao YF; Hu CM; Hong M; Sun XY; Li H; Liu Y; Fu X; Sun H
Fitoterapia; 2013 Jan; 84():208-12. PubMed ID: 23237733
[TBL] [Abstract][Full Text] [Related]
26. The inhibition of UDP-glucuronosyltransferases (UGTs) by vitamin A.
Liu X; Cao YF; Dong PP; Zhu LL; Zhao Z; Wu X; Fu ZW; Huang CT; Fang ZZ; Sun HZ
Xenobiotica; 2017 May; 47(5):376-381. PubMed ID: 27359323
[TBL] [Abstract][Full Text] [Related]
27. Inhibition potential of glimepiride (gli) towards important UDP-glucuronosyltransferase (UGT) isoforms in human liver.
Fu JF; Ren QY; Zhang NY; Gao B; Tu YY; Fu GQ; Li DH; Zhang YS
Pharmazie; 2012 Aug; 67(8):715-7. PubMed ID: 22957438
[TBL] [Abstract][Full Text] [Related]
28. Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases.
Uchaipichat V; Mackenzie PI; Elliot DJ; Miners JO
Drug Metab Dispos; 2006 Mar; 34(3):449-56. PubMed ID: 16381668
[TBL] [Abstract][Full Text] [Related]
29. Selectivity for inhibition of nilotinib on the catalytic activity of human UDP-glucuronosyltransferases.
Ai L; Zhu L; Yang L; Ge G; Cao Y; Liu Y; Fang Z; Zhang Y
Xenobiotica; 2014 Apr; 44(4):320-5. PubMed ID: 24066723
[TBL] [Abstract][Full Text] [Related]
30. Investigation of UDP-glucuronosyltransferases (UGTs) inhibitory properties of carvacrol.
Dong RH; Fang ZZ; Zhu LL; Liang SC; Ge GB; Yang L; Liu ZY
Phytother Res; 2012 Jan; 26(1):86-90. PubMed ID: 21544887
[TBL] [Abstract][Full Text] [Related]
31. Characterization of N-glucuronidation of 4-(5-pyridin-4-yl-1H-[1,2,4]triazol-3-yl) pyridine-2-carbonitrile (FYX-051): a new xanthine oxidoreductase inhibitor.
Omura K; Nakazawa T; Sato T; Iwanaga T; Nagata O
Drug Metab Dispos; 2007 Dec; 35(12):2143-8. PubMed ID: 17761779
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the inhibition potential of parthenolide and micheliolide on various UDP-glucuronosyltransferase isoforms.
Gao WF; Li YX; Zhang WH; Tao R; Yin TT; Wang YJ; Liu LN; Fu ZW; Li SN; Liu NR; Zhang H; Liu G; Zhao LZ; Zhang XP; Zhang CZ
Xenobiotica; 2019 Oct; 49(10):1158-1163. PubMed ID: 30484368
[TBL] [Abstract][Full Text] [Related]
33. Glucuronidation of the broad-spectrum antiviral drug arbidol by UGT isoforms.
Song JH; Fang ZZ; Zhu LL; Cao YF; Hu CM; Ge GB; Zhao DW
J Pharm Pharmacol; 2013 Apr; 65(4):521-7. PubMed ID: 23488780
[TBL] [Abstract][Full Text] [Related]
34. Substrate-dependent modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1) by propofol in recombinant human UGT1A1 and human liver microsomes.
Mano Y; Usui T; Kamimura H
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):211-4. PubMed ID: 17697043
[TBL] [Abstract][Full Text] [Related]
35. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
[TBL] [Abstract][Full Text] [Related]
36. Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes.
Williams JA; Ring BJ; Cantrell VE; Campanale K; Jones DR; Hall SD; Wrighton SA
Drug Metab Dispos; 2002 Nov; 30(11):1266-73. PubMed ID: 12386134
[TBL] [Abstract][Full Text] [Related]
37. In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions.
Zheng YF; Min JS; Kim D; Park JB; Choi SW; Lee ES; Na K; Bae SK
Molecules; 2016 Aug; 21(8):. PubMed ID: 27529203
[TBL] [Abstract][Full Text] [Related]
38. Interaction between oblongifolin C and UDP-glucuronosyltransferase isoforms in human liver and intestine microsomes.
Gao C; Shi R; Wang T; Tan H; Xu H; Ma Y
Xenobiotica; 2015; 45(7):578-85. PubMed ID: 25714435
[TBL] [Abstract][Full Text] [Related]
39. Alteration of the function of the UDP-glucuronosyltransferase 1A subfamily by cytochrome P450 3A4: different susceptibility for UGT isoforms and UGT1A1/7 variants.
Ishii Y; Koba H; Kinoshita K; Oizaki T; Iwamoto Y; Takeda S; Miyauchi Y; Nishimura Y; Egoshi N; Taura F; Morimoto S; Ikushiro S; Nagata K; Yamazoe Y; Mackenzie PI; Yamada H
Drug Metab Dispos; 2014 Feb; 42(2):229-38. PubMed ID: 24255116
[TBL] [Abstract][Full Text] [Related]
40. Regulation profile of phosphatidylcholines (PCs) and lysophosphatidylcholines (LPCs) components towards UDP-glucuronosyltransferases (UGTs) isoforms.
Gao X; Qu H; Ai CZ; Cao YF; Huang T; Chen JX; Zeng J; Sun XY; Hong M; Gonzalez FJ; Liu Z; Fang ZZ
Xenobiotica; 2015 Mar; 45(3):197-206. PubMed ID: 25259654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
